LX31 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lexicon Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 2.894 EUR -2.69% Market Closed

Market Cap: €418.1m

L	Lexicon Pharmaceuticals Inc F:LX31	US
D	Devon Energy Corp BMV:DVN	US
H	HIVE Blockchain Technologies Ltd F:HBF	CA
	Cipla Ltd NSE:CIPLA	IN
V	Verisign Inc SWB:VRS	US
	TYMLEZ Group Ltd ASX:TYM	AU
	Bilibili Inc F:71BB	CN
D	Domino's Pizza Inc XMUN:EZV	US
	Vext Science Inc F:VV5	CA
L	Lepanto Consolidated Mining Co XPHS:LC	PH
G	Genuine Parts Co XMUN:GPT	US
T	Tenet Healthcare Corp XMUN:THC1	US
	Grupo Bimbo SAB de CV OTC:BMBOY	MX
D	Dentsu Group Inc DUS:DEN	JP
	UIE PLC F:I55	MT

Profitability Summary

Lexicon Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

100% > 99%

Negative Operating Margin

-35%

Negative 3Y Average Operating Margin

-8.933%

Operating Margin is Increasing

-42.900% > -35%

Negative Net Margin

-37%

Negative 3Y Average Net Margin

-9.119%

Net Margin is Increasing

-43.567% > -37%

Negative Free Cash Flow Margin

-56%

Negative 3Y Average Free Cash Flow Margin

-8.062%

Free Cash Flow Margin is Increasing

-37.467% > -56%

Negative ROE

-16%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-272%

ROIC is Increasing

-279% > -26%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.